Patentability of methods of human enhancement
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Patentability of methods of human enhancement. / Nordberg, Ana.
I: Journal of Intellectual Property Law & Practice, Bind 10, Nr. 1, 01.2015, s. 19-28.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Patentability of methods of human enhancement
AU - Nordberg, Ana
PY - 2015/1
Y1 - 2015/1
N2 - This article explores how to apply patentability rules to human enhancement, particularly focusing on Article 53(c) of the European Patent Convention (EPC).The global size and value of the cosmetic and wellness market and industry allow for the prediction of considerable market potential for human enhancement. Patents will be instrumental for companies to protect investment in innovation and tap into this potentially valuable market.The European patent system contains, in Article 53(c) EPC, an exception from patentability for methods for treatment and diagnostic methods. Such rule was created, and subsequently developed through European Patent Office (EPO) case law, by reference to the dichotomy between therapeutic and cosmetic methods. Subsuming enhancement methods under this patentability rule may be challenging. Ultimately, patentability of human enhancement will depend on the concept of health, its future evolution and the corresponding public policy choices. This article seeks to provide prospective patentees with guidance and awareness concerning the patentability of methods for human enhancement.
AB - This article explores how to apply patentability rules to human enhancement, particularly focusing on Article 53(c) of the European Patent Convention (EPC).The global size and value of the cosmetic and wellness market and industry allow for the prediction of considerable market potential for human enhancement. Patents will be instrumental for companies to protect investment in innovation and tap into this potentially valuable market.The European patent system contains, in Article 53(c) EPC, an exception from patentability for methods for treatment and diagnostic methods. Such rule was created, and subsequently developed through European Patent Office (EPO) case law, by reference to the dichotomy between therapeutic and cosmetic methods. Subsuming enhancement methods under this patentability rule may be challenging. Ultimately, patentability of human enhancement will depend on the concept of health, its future evolution and the corresponding public policy choices. This article seeks to provide prospective patentees with guidance and awareness concerning the patentability of methods for human enhancement.
KW - Faculty of Law
KW - Patents
KW - Ethics
KW - Nanotechnology
KW - Synthetic Biology
KW - Human enhancement
KW - Human Engineering
KW - EPC
KW - Morality exception
U2 - 10.1093/jiplp/jpu203
DO - 10.1093/jiplp/jpu203
M3 - Journal article
VL - 10
SP - 19
EP - 28
JO - Journal of Intellectual Property Law & Practice
JF - Journal of Intellectual Property Law & Practice
SN - 1747-1532
IS - 1
ER -
ID: 128608251